Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Samuel Insider Profile
4 Followers
John Samuel, Director at Xeros Technology, holds 15.54M shares in Tissue Regenix (Ticker: GB:TRX), holds 1.48M shares in Xeros Technology (Ticker: GB:XSG). Most recently, John Samuel Bought ― shares of Tissue Regenix on Aug 09, 2017 for an estimated value of 200.00K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+59.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by John Samuel
John Samuel's Trading History
Xeros Technology
Nov 12, 2015
Director
Informative Buy
50.00K
£18.10K
Tissue Regenix
Aug 09, 2017
Director
Informative Buy
200.00K
£10.41M
List of latest transactions for each holding click on a transaction to see John Samuel's performance on stock
You May Also Like
John Samuel insider profile FAQ
What is the percentage of profitable transactions made by John Samuel?
The percentage of profitable transactions made by John Samuel is 33%.
What is the average return per transaction made by John Samuel?
The average return per transaction made by John Samuel is 59.70%.
What stocks does John Samuel hold?
John Samuel holds: GB:XSG, GB:TRX stocks.
What was John Samuel’s latest transaction?
John Samuel latest transaction was an Informative Buy of 200.00K.
What was John Samuel's most profitable transaction?
John Samuel’s most profitable transaction was an Informative Buy of GB:XSG stock on May 1, 2014. The return on the trade was 218.80%.
What is John Samuel's role in Xeros Technology?
John Samuel's role in Xeros Technology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.